¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"v"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
¿µ¹® valve ÇÑ±Û ÆÇ¸·
¼³¸í   
  °ü È¤Àº Åë·Î¿¡ Àִ ¸·°ú °°Àº ÁÖ¸§. ³»¿ë¹°ÀÇ ¿ª·ù¸¦ ¸·´Â´Ù.
  
  1.½ÉÀåÆÇ¸·: ¿ì½É¹æ°ú ¿ì½É½Ç»çÀÌÀÇ »ï÷ÆÇ, Á½ɹæ°ú Á½ɽǻçÀÌÀÇ ½Â¸ðÆÇ, ¿ì½É½Ç°ú Æóµ¿¸Æ»çÀÌÀÇ Æóµ¿¸Æ¹Ý¿ùÆÇ, Á½ɽǰú ´ëµ¿¸Æ»çÀÌÀÇ ´ëµ¿¸Æ¹Ý¿ùÆÇÀÌ ÀÖ´Ù.
  
  2.Á¤¸ÆÆÇ¸·: Á¤¸Æ¿¡¼­ ¹ß°ßµÇ´Â ³»¸·ÀÇ ÀÛÀº Ã· È¤Àº ÁÖ¸§. Åº·Â¼ºÀÌ Àû¾î ¿ª·ùµÇ±â ½¬¿î Á¤¸ÆÇ÷ÀÇ È帧À» ¿ª·ù¾øÀÌ Á¤»óÀûÀΠ¹æÇâÀ¸·Î Áö¼ÓµÇµµ·Ï ÇØÁØ´Ù.
  
  3.ÀΰøÆÇ¸·: ½ÉÀåÆÇ¸·ºÎÁ·À̳ª ½ÉÀåÆÇ¸·ÇùÂøÀÌ À־õÀÌ»ó ÀÚ½ÅÀÇ ÆÇ¸·À¸·Î´Â »ýÁ¸ÀÌ ºÒ°¡´ÉÇÒ ¶§ ´ë½Å À̽ÄÇϰԠµÇ´Â ÀΰøÆÇ¸·À» ¸»ÇÑ´Ù. Å©°Ô µ¿¹°ÀÇ Á¶Á÷À» ÀÌ¿ëÇÑ °Í°ú ±×·¸Áö ¾ÊÀº °ÍÀ¸·Î ¾çºÐÇÒ ¼ö ÀÖ´Ù. µ¿¹°ÀÇ Á¶Á÷À» ÀÌ¿ëÇÑ °ÍÀº ÁַΠµÅÁö³ª ¼ÒÀÇ ÆÇ¸· ¶Ç´Â ½É¿Ü¸· µîÀ» ÀÌ¿ëÇϸç, ±×·¸Áö ¾ÊÀº °ÍÀº Æ¯¼öÇÑ ±Ý¼ÓÀ» ÀÌ¿ëÇÏ¿© ¸¸µç´Ù.
¿µ¹® variant ÇÑ±Û º¯Çü, º¯ÀÌ
¼³¸í   
  1.¼Ò¼ÓÇϴ ºÎ·ù¿Í ´Ù¸¥ ¼ºÁúÀ» °®´Â °ÍÀÇ ÃÑĪ, ¶Ç´Â ÀϺΠƯº°ÇÑ ¼ºÁú¸¸ Æ²¸®´Â °Í¿¡ »ç¿ëµÇ´Â ´Ü¾î. 
  
  2. »ý¹°Çл󠵿Á¾ÀÇ »ý¹°¿¡¼­ º¼ ¼ö Àִ ÇüÁúÀÇ Â÷ÀÌ.
¿µ¹® varicocele ÇÑ±Û Á¤°èÁ¤¸Æ·ù
¼³¸í   
  Á¤»óÀÇ µ¢±¼Á¤¸Æ¾ò±âÀÇ Á¤¸Æ·ù·Î¼­ À½³¶ÀÇ ÇǺξƷ¡¼­ Ã»»öÀ¸·Î º¸À̴ ¹ú·¹ ÁָӴϸð¾çÀÇ Á¾Ã¢À» ÀÏÀ¸Å°°í, À½³¶³»¿¡¼­ ¿¬¼ÓÀûÀΠ°ßÀÎÅëÀ̳ª µÐÅëÀ» ¼ö¹ÝÇÑ´Ù. °¡²û ³²¼ººÒÀÓÀÇ ¿øÀÎÀ¸·Î ÀÛ¿ëÇϱ⵵ ÇÑ´Ù.
  
  Á¤°èÁ¤¸Æ·ù
¿µ¹® varicose vein ÇÑ±Û Á¤¸Æ·ù¼ºÁ¤¸Æ
¼³¸í   
  È®ÀåµÇ°í ´Ã¾î³­ Á¤¸ÆÀ¸·Î ÀϹÝÀûÀ¸·Î ³Ò´Ù¸®ÀÇ ÇÇÇÏÁ¶Á÷¿¡¼­ º¼ ¼ö ÀÖÀ¸¸ç, Á¤¸ÆÆÇÀÇ ºÎÁ·À» µ¿¹ÝÇÑ´Ù. ±Ùº»ÀûÀΠġ·á´Â È®ÀåµÈ Á¤¸Æ·ùÀÇ ÀýÁ¦ÀÌ´Ù.
¿µ¹® variola ÇÑ±Û ¸¶¸¶, µÎâ
¼³¸í   
  ¸¶¸¶¹ÙÀÌ·¯½º(poxvirus)¿¡ ÀÇÇØ¼­ ÀϾ´Â ±Þ¼º¹ýÁ¤ Àü¿°º´. Àẹ±â´Â 12ÀÏÀ̰í, À̾ À̻󼺹߿­°æ°ú°¡ ½ÃÀ۵ȴÙ. Á¦1±â´Â 3~4ÀÏ °è¼ÓµÇ´Âµ¥ ÀÌ ±â°£¿¡ ¹ß¿­°ú 1°ú¼º È«¹Ý, ¶Ç´Â Á¡ÃâÇ÷¹ÝÀÌ ±¸°£¿¡ »ý±ä´Ù. ±×°ÍÀÌ ¼Ò¸êµÇ°í Ã¼¿ÂÀÌ ÀÏÀϰ£ Çϰ­Çϳª, À̾ ´Ù½Ã »ó½ÂÇϸç À̶§¿¡ ±¸ÁøÀÌ ¾ó±¼, ¼Õ, ¹ß¿¡ ³ªÅ¸³ª¼­ ¼öÆ÷È­µÇ°í, ±Þ¼ÓÈ÷ ³óÆ÷»óÀ¸·Î µÈ´Ù. º´º¯Àº ¼Õ¹Ù´Ú, ¹ß¹Ù´Ú, ÆÈ´Ù¸®ÀÇ ¿øÀ§ºÎ¿¡¼­ ±¸°£À» ÇâÇØ¼­ ÁøÇàµÈ´Ù. °¢ º´º¯Àº Á¤È®ÇϰԠ°°Àº Å©±â¿Í ¹ß»ý½Ã±â°¡ °°Àº º´º¯À¸·Î µÑ·¯½ÎÀ̸ç, ÁַΠ¸öÀÇ ³íÃâºÎ¿¡ ³ªÅ¸³ª°í, °Üµå¶û, »ô°í¶û¿¡´Â ³ªÅ¸³ªÁö ¾Ê´Â´Ù. ³óÆ÷´Â Á߽ɺΰ¡ ÇÔ¸ôµÇ°í, µüÁö¸¦ Çü¼ºÇϸç 7~10ÀÏ ÈÄ¿¡ Å»¶ôµÇ¾î, ÀÛÀº ÇÔ¿ä, Å»»öµÈ ¹ÝÈçÀ» ³²±ä´Ù. ´Ù¸¥ Áõ»óÀ¸·Î Æó·Å, °üÀý¿°, °ñ¼ö¿°, ÇǺΠ¹× ±¸°­ Á¡¸·º´º¯ÀÇ ÃâÇ÷ÀÌ Æ÷ÇԵȴÙ. µîÂÊÅëÁõ, µÎÅë ¹× ¼è¾àÀÌ ÈçÈ÷ ¼ö¹ÝµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • vagal
    ¹ÌÁֽŰæ-
  • vagal arrhythmia
    ¹ÌÁֽŰæºÎÁ¤¸Æ
  • vagal bradycardia
    ¹ÌÁֽŰæ´À¸°¸Æ, ¹ÌÁֽŰ漭¸Æ
  • vagal neuralgia
    ¹ÌÁֽŰæÅë
  • vagal reflex
    ¹ÌÁֽŰæ¹Ý»ç
  • vagal tone
    ¹ÌÁֽŰæ±äÀåµµ
  • vagina
    1. Áú 2. Áý
  • vaginal
    1. Áú- 2. Áý- 3. °íȯÁý¸·-, °íȯÃʸ·-
  • vaginal adenosis
    Áú»ùÁõ, Áú¼±Áõ
  • vaginal artery
    Áúµ¿¸Æ
  • vaginal canal
    Áú°ü
  • vaginal cancer
    Áú¾Ï
  • vaginal delivery
    Áú(½Ä)ºÐ¸¸
  • vaginal discharge
    ÁúºÐºñ¹°
  • vaginal examination
    Áú°Ë»ç, ³»Áø
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • vaginoplasty
    Áú¼ºÇü¼ú
  • vaginoscope
    Áúº¸°³, Áú°æ
  • vaginoscopy
    Áúº¸°³°Ë»ç(¹ý), Áú°æ°Ë»ç(¹ý)
  • vaginosis
    ÁúÁõ
  • vaginovesical fistula
    (¢¡ vesicovaginal fistula) ¹æ±¤Áú»û±æ, ¹æ±¤Áú·ç
  • vagotomy
    ¹ÌÁֽŰæÀý´Ü(¼ú)
  • vagotonia
    ¹ÌÁֽŰæ±äÀå(Áõ)
  • vagus nerve
    ¹ÌÁֽŰæ
  • valence
    ¿øÀÚ°¡
  • valgus
    ¿Ü¹Ý-, ¹Ù±ù±ÁÀº-
  • validity
    Ÿ´ç¼º, È¿·Â, Ÿ´çµµ
  • valine
    ¹ß¸°
  • valium
    ¹ß·ý
  • vallecula
    °è°î
  • valleculitis
    °è°î¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • vacuum extraction
    ÈíÀԺи¸, Áø°øºÐ¸¸
  • vacuum headache
    Áø°øµÎÅë
  • vacuum investing
    Áø°ø¸Å¸ô
  • vacuum suction
    Áø°øÈíÀÎ
  • vacuum tube
    Áø°ø°ü
  • vagabond¡¯s leukoderma
    ºÎ¶ûÀÚ¹é»öÇǺÎÁõ
  • vagal
    ¹ÌÁÖ-, ¹ÌÁֽŰæ-
  • vagal arrhythmia
    ¹ÌÁֽŰæºÎÁ¤¸Æ
  • vagal bradycardia
    ¹ÌÁֽŰæ´À¸°¸Æ
  • vagal neuralgia
    ¹ÌÁֽŰæÅë
  • vagal reflex
    ¹ÌÁֽŰæ¹Ý»ç
  • vagal tone
    ¹ÌÁֽŰæ±äÀå
  • vagina
    Áú
  • vaginal
    Áú-
  • vaginal adenosis
    Áú»ùÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • VDRL flocculation test
    VDRL¸é»ó¹ÝÀÀ.
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • Veillonella parvula
    º£ÀϷγڶó ÆÄ¸£ºÒ¶ó±Õ
  • Venezuelan equine encephallomyelitis
    º£³×ÁÖ¿¤¶ó ¸» ³ú¿°¹ÙÀÌ·¯½º
  • Venezuelan equine encephal[omyel]itis
    º£³×ÁÖ¿¤¶ó ¸» ³ú¿°¹ÙÀÌ·¯½º
  • Verhoeff Van Gieson stain
    º£¸£È¸ÇÁ ¹Ý ±â½¼ ¿°»ö
  • Verrocay body
    º£·ÎÄÉÀÌ ¼Òü
  • VESA(Video Electronic Standards Association)
    ºñµð¿À ÀüÀÚ Ç¥ÁØÈ­ À§¿øÈ¸, º£»ç
  • VGA (video graphic array)
    ºêÀÌÁö¿¡ÀÌ
  • Vi antigen
    ViÇ׿ø.
  • VI= ventilation index
    ȯ±âÁö¼ö.
  • Vibrio
    ºñºê¸®¿À(¼Ó)
  • Vibrio cholerae
    ÄÝ·¹¶ó±Õ.
  • Vibrio cholerae
    ÄÝ·¹¶ó±Õ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • vaccinia necrosum ³ª
    ±«»ç¼º Á¾µÎÁõ.
  • vaccinia virus
    ¿ìµÎ¹ÙÀÌ·¯½º.
  • vaccinia virus
    ¿ìµÎ¹ÙÀÌ·¯½º, ¹é½Ã´Ï¾Æ¹ÙÀÌ·¯½º
  • vaccinia ³ª vaccina
    ¿ìµÎ, ¹é½Ã´Ï¾Æ, Á¾µÎÁõ(ðúÔãñø).
  • vaccinial
    ¹é½ÅÀÇ
  • vaccinid
    Á¾µÎÁø(ðúÔãòÖ).
  • vaccinization
    Á¾µÎÈ­, ¿ÏÀüÁ¾µÎ¹ý(èÇîï ðúÔãÛö).
  • vaccinoid
    °¡µÎ(Ê£Ôã).
  • vaccinoid reaction
    °¡µÎ¼º ¹ÝÀÀ(Ê£Ôãàõ Úãëë).
  • vaccinola
    ºÎµÎ(ÜùÔã), Á¾µÎÈÄÀÇ ºÎ¼öµÎÁø.
  • vaccinophobia
    Á¾µÎ°øÆ÷(Áõ)(ðúÔãÍðø×ñø).
  • vacuolar
    °øÆ÷(Íöøà)ÀÇ
  • vacuolar degeneration
    °øÆ÷¼º º¯¼º(Íöøààõ ܨàõ)
  • vacuolar myelopathy
    °øÆ÷¼º ô¼öº´Áõ(Íöøààõ ô±âÐÜ»ñø)
  • vacuolar nephropathy
    °øÆ÷¼º ½Åº´Áõ(Íöøààõ ãìÜ»ñø)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Vas prominens
    À¶±âÇ÷°ü
    [¿¾ ¿ë¾î] À¶±â¸Æ°ü
  • Vas prominens
    À¶±âÇ÷°ü
    [¿¾ ¿ë¾î] À¶±âÇ÷°ü
  • Vas spirale
    ³ª¼±Ç÷°ü
    [¿¾ ¿ë¾î] ³ª¼±Ç÷°ü
  • Vas vasorum
    ¸Æ°üº®Ç÷°ü
    [¿¾ ¿ë¾î] ¸Æ°üº®Ç÷°ü
  • Vasa vasorum
    ¸Æ°üº®Ç÷°ü
    [¿¾ ¿ë¾î] ÀÚ¾ç¸Æ°ü
  • Vasa vasorum
    ¸Æ°üº®Ç÷°ü
    [¿¾ ¿ë¾î] ÀÚ¾çÇ÷°ü
  • Vascular abundance (Vascular nevus)
    ¸Æ°ü°ú´Ù (¸Æ°ü¸ð¹Ý)
    [¿¾ ¿ë¾î] ¸Æ°ü°ú´Ù
  • Vascular cecal fold
    ¸·Ã¢ÀÚÇ÷°üÁÖ¸§
    [¿¾ ¿ë¾î] ¸ÍÀåÇ÷°üÁÖ¸§
  • Vascular circle
    ¸Æ°ü°í¸®
    [¿¾ ¿ë¾î] ¸Æ°ü·û
  • Vascular lamina
    ¸Æ°üÆÇ
    [¿¾ ¿ë¾î] ¸Æ°üÃþ
  • Vascular layer
    ¸Æ°üÃþ
    [¿¾ ¿ë¾î] ¸Æ°üÃþ
  • Vascular layer
    Ç÷°üÃþ
    [¿¾ ¿ë¾î] Ç÷°üÃþ
  • Vascular layer of eyeball
    ¾È±¸Ç÷°üÃþ
    [¿¾ ¿ë¾î] ¾È±¸¸Æ°üÃþ
  • Vascular layer of lens
    ¼öÁ¤Ã¼¸Æ°üÃþ
    [¿¾ ¿ë¾î] ¼öÁ¤Ã¼¸Æ°üÃþ
  • Vascular nerves
    ¸Æ°üº®½Å°æ
    [¿¾ ¿ë¾î] ¸Æ°ü½Å°æ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • vasospasm
    Ç÷°ü¿¬Ãà
    úìηÕýõê
  • vasovagal
    Ç÷°ü¹ÌÁֽŰæ
    úìηڻñËãêÌè
  • vault
    ̵ˌ
    ô¸î¡
  • vegetant intravascular h.
    Áõ½ÄÇ÷°ü³»Ç÷°ü³»ÇÇÁ¾
    ñòãÖúìηҮúìηҮù«ðþ
  • vegetative nervous s. -> autonomic nervous s.
    ÀÚÀ²½Å°æ°è
    í»ëÏãêÌèͧ÷Ö
  • vegetative state
    ½Ä¹°Àΰ£»óÅÂ
    ãÕÚªìÑÊàßÒ÷¾
  • vehicle p.
    ¿î¹Ý´Ü¹éÁú
    ê¡ÚæÓ±ÛÜòõ
  • vein
    Á¤¸Æ
    ð¡Øæ
  • velum interpositum
    Áß°£µ¤°³
    ñéÊ൤°³
  • venereal d.
    ¼ºº´
    àõÜ»
  • venography
    Á¤¸ÆÁ¶¿µ¼ú
    ð¡Øæðãç¯âú
  • venous
    Á¤¸Æ-
    ð¡Øæ-
  • venous a.
    Á¤¸Æ°¢
    ð¡ØæÊÇ
  • venous s.
    Á¤¸Æµ¿
    ð¡ØæÔ×
  • ventilation
    ȯ±â
    üµÑ¨
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • van Slyke method
    ¹Ý ½½¶óÀÌÅ©¹ý(Ûö)
  • van't Hoff complex
    ¹ÝÆ® È£ÇÁ º¹ÇÕü (ÜÜùêô÷)
  • van't Hoff equation
    ¹ÝÆ® È£ÇÁ ¹æÁ¤½Ä (Û°ïïãÒ)
  • van't Hoff factor
    ¹ÝÆ® È£ÇÁ ÀÎÀÚ(ì×í­)
  • van't Hoff isobar
    ¹ÝÆ® È£ÇÁ µî¾Ð¼±(ÔõäâàÊ)
  • van't Hoff isochore
    ¹ÝÆ® È£ÇÁ µî¿ë¼±(Ôõé»àÊ)
  • van't Hoff limiting law
    ¹ÝÆ® È£ÇÁ Á¦ÇÑ ¹ýÄ¢(ð¤ùÚÛööÎ)
  • van't Hoff plot
    ¹ÝÆ® È£ÇÁ Ç÷Ô
  • vancomycin
    ¹ÝÄÚ¸¶À̽Å
  • vanilmandelic acid
    ¹Ù´Ò¸¸µ¨»ê(ß«)
  • vapor diffusion methed
    Áõ±â(ñúѨ) È®»ê¹ý(üªß¤Ûö)
  • vapor phase chromatography
    Áõ±â»ó(ñúѨßÓ) Å©·Î¸¶Åä±×·¡ÇÇ
  • vapor pressure osmometer
    Áõ±â¾Ð(ñúѨäâ) »ïÅõ°è(ß¶÷âͪ)
  • vapor-liquid partition chromatography
    Áõ±â-¾×ü (ñúѨäûô÷) ºÐ¹è(ÝÂÛÕ) Å©·Î¸¶Åä±×·¡ÇÇ
  • variable
    º¯¼ö(ܨâ¦)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • valvular regurgitation
    ÆÇ¿ª·ù·®
  • valvular stenosis
    ÆÇÇùÂø
  • valvulitis
    ½ÉÆÇ¸·¿°
  • valvulotomy
    ÆÇ¸·Àý°³¼ú
  • vanishing
    ¼ÒÅð
  • vanishing tumor
    Àϰú¼ºÁ¾¾ç»óÀ½¿µ, Àϰú¼º¿±°£Èä¼öÀú·ù(»ó)
  • variability
    º¯À̼º, º¯µ¿¼º
  • variable
    º¯¼ö, °¡º¯ÀÇ, º¯È­ÀÖ´Â
  • variable bandwidth technique
    ´Ùº¯Á֯ļöÆø±â¹ý
  • variant
    º¯ÀÌü, º¯Á¾, º¯ÁÖ
  • variation
    º¯ÀÌ, º¯µ¿
  • varicella
    ¼öµÎ
  • varices
    Á¤¸Æ·ù
  • varicocele
    Á¤°èÁ¤¸Æ·ù
  • varicocele embolization
    Á¤°èÁ¤¸Æ·ù»öÀü¼ú
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 3
V/S Vital Signs; Ȱ·ÂÁõÈÄ
  1. Body Temperature; ü¿Â
  2. Blood Pressure; Ç÷¾Ð
  3. Heart Rate; ½É¹Ú¼ö
  4. Respiratory; È£Èí¼ö
v/v percent volume in volume
v/w volume per weight
V1 TP V6 ventral 1 to ventral 6 [chest leads in ECG]
VA vacuum aspiration; valproic acid; vasodilator agent; ventricular aneurysm; ventricular arrhythmia; ventriculoatrial; ventroanterior; vertebral artery; Veterans Administration; Veterans Affairs; vincristine, adriamycin; viral antigen; visual acuity; visual aid; visual axis; volt-ampere; volume-average
VA alveolar ventilation
Va alveolar ventilation
VA shunt Ventriculo-Atrial shunt
Va/Q alveolar ventilation/perfusion
VA/QC ventilation-perfusion [ratio]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 3
V ventricular
V vermilion
V vimentin
V vinblastine
V virus
V 1/2 voltage
v BMD volumetric bone mineral density
V L variable light
V O(2) O(2) uptake
V'E Ventilation
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • JrId: 2612
    JournalTitle: viruses, bacteria, fungi.
    MedAbbr: Microb Releases
    ISSN: 0940-9653
    ESSN:
    IsoAbbr: Microb. Releases
    NlmId: 9301294
  • JrId: 2704
    JournalTitle: The Veterinary clinics of North America. Equine practice.
    MedAbbr: Vet Clin North Am Equine Pract
    ISSN: 0749-0739
    ESSN:
    IsoAbbr: Vet. Clin. North Am. Equine Pract.
    NlmId: 8511904
  • JrId: 2708
    JournalTitle: The Veterinary clinics of North America. Food animal practice.
    MedAbbr: Vet Clin North Am Food Anim Pract
    ISSN: 0749-0720
    ESSN:
    IsoAbbr: Vet. Clin. North Am. Food Anim. Pract.
    NlmId: 8511905
  • JrId: 3370
    JournalTitle: Veterinarstvi.
    MedAbbr: Veterinarstvi
    ISSN: 0506-8231
    ESSN:
    IsoAbbr:
    NlmId: 102017
  • JrId: 3371
    JournalTitle: Veterinary medical review.
    MedAbbr: Vet Med Rev
    ISSN: 0506-8274
    ESSN:
    IsoAbbr:
    NlmId: 60752
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • V73
    Bus occupant injured in collision with car, pick-up truck or van
    ½Â¿ëÂ÷, ÇȾ÷Æ®·° ¶Ç´Â ¹ê°ú Ãæµ¹·Î ´ÙÄ£ ¹ö½º ž½ÂÀÚ
  • V77
    Bus occupant injured in collision with fixed or stationary object
    °íÁ¤ ¶Ç´Â Á¤ÁöµÈ ¹°Ã¼¿Í Ãæµ¹·Î ´ÙÄ£ ¹ö½º ž½ÂÀÚ
  • V74
    Bus occupant injured in collision with heavy transport vehicle or bus
    ´ëÇüÈ­¹°Â÷ ¶Ç´Â ¹ö½º¿Í Ãæµ¹·Î ´ÙÄ£ ¹ö½º ž½ÂÀÚ
  • V71
    Bus occupant injured in collision with pedal cycle
    ÀÚÀü°Å¿Í Ãæµ¹·Î ´ÙÄ£ ¹ö½º ž½ÂÀÚ
  • V70
    Bus occupant injured in collision with pedestrian or animal
    º¸ÇàÀÚ ¶Ç´Â µ¿¹°°úÀÇ Ãæµ¹·Î ´ÙÄ£ ¹ö½º ž½ÂÀÚ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • vacuolar myelopathy
    °øÆ÷¼º ô¼öº´Áõ
  • vacuolate
    °øÆ÷È­ÇÏ´Ù
    ÀÛÀº °£°Ý ȤÀº °øÆ÷¸¦ Çü¼ºÇÏ´Ù.
  • vacuolated virus
    °øÆ÷¼º ¹ÙÀÌ·¯½º
  • vacuole
    °øÆ÷, ¾×Æ÷, ¼ÒÆ÷
    ¼¼Æ÷ÀÇ ¿øÇüÁú ³»¿¡ Çü¼ºµÈ ÀÛÀº °£±ØÀ̳ª ¼ÒÆ÷.
  • vacuome
    Áß¼ºÀû °øÆ÷, ¹ÙÄí¿È
    ¼¼Æ÷ ³»¿¡ Áß¼ºÀ¸·Î ¿°»öµÇ´Â °øÆ÷°è.
  • vacuum
    Áø°ø
    Áø°ø, °ø±â ¶Ç´Â ´Ù¸¥ °¡½º¸¦ ¹èÃâÇÑ °ø°£, °ø±â ¶Ç´Â °¡½º°¡ ¾ø´Â °ø°£.
  • vacuum baking
    Áø°ø ¼Ò¼º
    µµÀç ¼Ò¼º¿¡´Â Áø°ø ¼Ò¼º°ú º¸Åë ¼Ò¼º¹ýÀÌ Àִµ¥ Áø°ø ¼Ò¼ºÀº furnace ³»ºÎ¸¦ Áø°ø ÆßÇÁ·Î °¨¾ÐÇϸ鼭 Áø°øÇÏ¿¡¼­ ¼Ò¼ºÇÏ´Â °ÍÀ¸·Î µµÀçÀÇ ³»ºÎ¿¡ ±âÆ÷°¡ »ý±âÁö ¾Ê°í °ß°íÇÏ¸ç ¾Æ¸§´Ù¿î µµÀ縦 Á¦ÀÛÇÒ ¼ö ÀÖ´Â ¼Ò¼º¹ýÀÌ´Ù.
  • vacuum casting
    Áø°ø ÁÖÁ¶
    Áø°ø »óÅ¿¡¼­ ±Ý¼ÓÀ» ÁÖÁ¶ÇÏ´Â °Í.
  • vacuum chamber
    Áø°ø½Ç
    Áø°ø »óÅÂÀÇ °¡¿­°­À» °¡¸®Å²´Ù.
  • vacuum desiccator
    Áø°ø °ÇÁ¶±â
  • vacuum drying
    Áø°ø °ÇÁ¶
  • vacuum extraction
    ÈíÀÎ ºÐ¸¸, ÈíÀÎ ºÐ¸¸¼ú
  • vacuum gauge
    Áø°ø°è
    µµÀç·ÎÀÇ ÇÑ ±¸Á¶·Î Áø°øÀÇ ¾çÀ» Ç¥½ÃÇÏ´Â °Í.
  • vacuum investing
    Áø°ø ¸Å¸ô
  • vacuum mixing
    Áø°ø È¥ÇÕ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
vaccinate To administer a vaccine.
(05 Mar 2000)
vaccination <procedure> The introduction of vaccine into the body for the purpose of inducing immunity. Coined originally to apply to the injection of smallpox vaccine, the term has come to mean any immunising procedure in which vaccine is injected.
Origin: L. Vacca = cow
(18 Nov 1997)
vaccination, anthrax A series of six shots over six months and booster shots annually, the anthrax vaccine now in use in the usa was first developed in the 1950s and approved by the food and drug administration for general use in 1970. It is produced by the michigan biologic products institute of michigan's department of health and is given routinely to veterinarians and others working with livestock. In december, 1997 it was announced that all us military would receive the vaccine, as do the military in the uk and russia, the reason being concern that anthrax might be used in biologic warfare.
(12 Dec 1998)
vaccination, chickenpox This vaccine prevents the common disease known as chickenpox (varicella zoster). While chickenpox is often considered a trivial illness, it can cause significant lost time on the job and in school and have serious complications including ear infections, pneumonia, and infection of the rash with bacteria, inflammation of the brain (encephalitis) leading to difficulty with balance and coordination (cerebellar ataxia), damaged nerves (palsies), and reye's syndrome, a potentially fatal complication. The vaccination requires only one shot given at about a year of age. If an older person has not had chickenpox, the shot may be given at any time. There have been few significant reactions to the chickenpox vaccine. All children, except those with a compromised immune system, should have the vaccination.
(12 Dec 1998)
vaccination, children's In the United States, it is recommended that all children receive vaccination against: - hepatitis b - diphtheria, tetanus, pertussis - haemophilus influenzae type b (hib), poliovirus, measles, mumps, rubella, varicella zoster virus (chickenpox). Every child in the u.s. Should have these vaccinations except when there are special circumstances and the child's doctor advises specifically against a vaccination.
(12 Dec 1998)
vaccination, dpt DPT immunization protects from diphtheria, pertussis (whooping cough), and tetanus and is given in a series of 5 shots at 2, 4, 6, 18 months of age and 4-6 years of age. Thanks to vaccination programs, these diseases have become less common. However, there are still unvaccinated individuals capable of carrying and passing diphtheria and pertussis to others who are not vaccinated. Tetanus bacteria are prevalent in natural surroundings, such as contaminated soil. See also vaccination, dtap.
(12 Dec 1998)
vaccination, dt DT (diphtheria and tetanus) vaccine does not protect from pertussis and is usually reserved for individuals who have had a significant adverse reaction to a dpt shot or who have a personal or family history of a seizure disorder or brain disease
(12 Dec 1998)
vaccination, dtap Like DPT, DTaP protects from diphtheria, pertussis (whooping cough) and tetanus. Dtap is the same as dtp, except that it contains only acellular pertussis vaccine which is thought to cause fewer of the minor reactions associated with immunization and is also probably less likely to cause the more severe reactions occasionally seen following pertussis vaccination. Dtap is currently recommended only for the shots given at 18 months and 4-6 years of age.
(12 Dec 1998)
vaccination, german measles See Vaccination, MMR.
(12 Dec 1998)
vaccination, haemophilus influenzae type b See vaccination, hib.
(12 Dec 1998)
vaccination, hepatitis a When immediate protection against hepatitis a (infectious hepatitis) is needed, immunoglobulins are used. Protection is effective only if given within 2 weeks of exposure and lasts but 2-4 months. Immunoglobulins can be used to protect household contacts of someone with acute viral hepatitis and travelers to regions with poor sanitation and high hepatitis a rates, when the traveler has to depart sooner than the vaccines can take effect (about 2 weeks). Travelers can receive the immunoglobulin and vaccine simultaneously and be protected immediately and for longer term. When immediate protection is not needed, hepatitis a vaccines are considered for individuals in high-risk settings, including frequent world travelers, sexually active individuals with multiple partners, homosexual men, individuals using illicit drugs, employees of daycare centres, and certain health care workers, and sewage workers. Two hepatitis a vaccines called havrix and vaqta are commercially available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection.
(12 Dec 1998)
vaccination, hepatitis b Hepatits B (hep B) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection. Vaccination, hepatitis b: hepatits b (hep b) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are usually given both hbig and vaccine to provide immediate and long term protection.
(12 Dec 1998)
vaccination, hib This vaccine is to prevent disease caused by the haemophilus influenzae type b (hib) bacteria. The h. Influenzae (h. Flu) bacteria can cause a range of serious diseases including meningitis with potential brain damage and epiglottitis with airway obstruction poisoning. The hib vaccine is usually given at 2, 4 and 6 months of age. A final booster is given at 12-15 months of age. Hib vaccine rarely causes severe reactions.
(12 Dec 1998)
vaccination, infectious hepatitis See Vaccination, hepatitis a.
(12 Dec 1998)
vaccination, measles See Vaccination, MMR. Vaccination, mmr: the standard vaccine given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination hould be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 3
  • Vaccines, Inactivated - »õâ Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins.
    Synonyms : Inactivated Vaccines
  • Vaccines, Marker - »õâ Vaccines used in conjunction with diagnostic tests to differentiate vaccinated animals from carrier animals. Marker vaccines can be either a subunit or a gene-deleted vaccine.
    Synonyms :
  • Vaccines, Subunit - »õâ Vaccines consisting of one or more antigens that stimulate a strong immune response. They are purified from microorganisms or produced by recombinant DNA techniques, or they can be chemically synthesized peptides.
    Synonyms : Subunit Vaccines
  • Vaccines, Synthetic - »õâ Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.
    Synonyms : Synthetic Antigens, Synthetic Immunogens, Vaccines, Chemical, Vaccines, Molecular, Vaccines, Semisynthetic, Recombinant Vaccines
  • Vaccines, Virosome - »õâ Vaccines using VIROSOMES as the antigen delivery system that stimulates the desired immune response.
    Synonyms : Virosome Vaccines
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 10 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 10 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ºñŸ¾¾Á¤1000mg - »õâ
Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à
A12903261 Ascorbic Acid
ÀϹÝÀǾàǰ | ±Þ¿©
ºñŸ¾¾Á¤500mg - »õâ
Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à
A12902571 Ascorbic Acid
ÀϹÝÀǾàǰ | »èÁ¦
ºñŸ¹Î¾¾Á¤ - »õâ
´ë¿õÁ¦¾à
A04300111 Ascorbic Acid
ÀϹÝÀǾàǰ | »èÁ¦
¹ÙÀÌÆä·ÑÁ¤ - »õâ
¼­¿ïÁ¦¾à
A37000941 Ascorbic Acid, Fursultiamine, Pyridoxine HCl, Riboflavin, Tocopherol Acetate
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¹Ù·ÎÄÚ¹ÎÁ¤ - »õâ
½ÅdzÁ¦¾à
A00303291 Ascorbic Acid, Cyanocobalamin, Fursultiamine, Pyridoxine HCl, Riboflavin, Tocopherol Acetate
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¹ÙÀ̸®¹öݼ¿ - »õâ
¿µÀÏÁ¦¾à
A16602621 ATSO
ÀϹÝÀǾàǰ | ±Þ¿©
¹Ù½ºÄÚݼ¿ - »õâ
¼­¿ïÁ¦¾à
A37001821 ATSO
ÀϹÝÀǾàǰ | ±Þ¿©
¹Ù½ºÅ¥¶óÆ®Á¤ - »õâ
Çѱ¹º£¸µ°ÅÀΰÖÇÏÀÓ
A07600181 Bamethan Sulfate
Àü¹®ÀǾàǰ | »èÁ¦
¾¾Á¦À̺ñŸ¸ÞÁøÄ°¼¿ - »õâ
¾¾Á¦ÀÌ
A01002291 Benfotiamine, Cyanocobalamin, Pyridoxine HCl
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¾¾Á¦À̺ñŸ¸ÞÁøÄ°¼¿50mg - »õâ
¾¾Á¦ÀÌ
A01002301 Benfotiamine, Cyanocobalamin, Pyridoxine HCl
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
visceral leishmaniasis leishmaniasis of the viscera
Ãâó: wordnet.princeton.edu/perl/webwn
variability the quality of being subject to variation unevenness: the quality of being uneven and lacking uniformity
Ãâó: wordnet.princeton.edu/perl/webwn
visceral pericardium epicardium: the innermost of the two layers of the pericardium
Ãâó: wordnet.princeton.edu/perl/webwn
visualization visual image: a mental image that is similar to a visual perception
Ãâó: wordnet.princeton.edu/perl/webwn
variable something that is likely to vary; something that is subject to variation; "the weather is one variable to be considered" liable to or capable of change; "rainfall in the tropics is notoriously variable"; "variable winds"; "variable expenses" a quantity that can assume any of a set of values variable star: a star that varies noticeably in brightness varying: marked by diversity or difference; "the varying angles of roof slope"; "nature is infinitely variable" a symbol (like x or y) that is used in mathematical or logical expressions to represent a variable quantity (used of a device) designed so that a property (as e.g. light) can be varied; "a variable capacitor"; "variable filters in front of the mercury xenon lights"
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • vaccinee
    ¹é½Å ÁÖ»ç(Á¾µÎ)¸¦ ¸ÂÀº »ç¶÷
  • vaccinia
    ¿ìµÎÁ¾;¹é½Å
  • vaccinization
    ¿¬¼Ó Á¾µÎ(¸é¿ªÀÌ µÉ ¶§±îÁöÀÇ)
  • vacillate
    Èçµé¸®´Ù
  • vacillate
    µ¿¿äÇÏ´Ù;(¸¶À½,»ý°¢ÀÌ)Èçµé¸®´Ù
  • vacillating
    µ¿¿äÇÏ´Â
  • vacillating
    µ¿¿äÇÏ´Â;¸Á¼³ÀÌ´Â;°á´Ü¼ºÀÌ ¾ø´Â;¿ìÀ¯ ºÎ´ÜÇÑ
  • vacillation
    µ¿¿ä; ¿ìÀ¯ºÎ´Ü
  • vacillation
    µ¿¿ä;Èçµé¸²;¸Á¼³ÀÓ;¿ìÀ¯ºÎ´Ü
  • vacillatory
    =VACILLATING
  • vacua
    vacuumÀÇ º¹¼ö I
  • vacuity
    °øÇã
  • vacuity
    °ø Çã;ºó°÷
  • vacuolar
    °øÆ÷(¾×Æ÷)ÀÇ(°¡ ÀÖ´Â)
  • vacuolate
    °øÆ÷ÀÇ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
v leave voluntarily
v the act of making something legally void
v leisure time away from work
v spend or take a vacation
v a dwelling (a second home) where you live while you are on vacation
v an area where many people go for recreation
v someone on vacation
v the act of taking a vacation
v someone on vacation
v cow-cockles
v European annual with pale rose-colored flowers
v European annual with pale rose-colored flowers
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 3
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á